The Prostate Cancer Dilemma Selecting Patients for Active Surveillance, Focal Ablation and Definitive Therapy /
This comprehensive text provides a complete description of the newest technologies to diagnose and manage the most common prostate cancer diagnosed today: low risk disease. The book reviews new data about genetic markers, transperineal mapping biopsy and mpMRI, how to apply each of these technologie...
Συγγραφή απο Οργανισμό/Αρχή: | |
---|---|
Άλλοι συγγραφείς: | , |
Μορφή: | Ηλεκτρονική πηγή Ηλ. βιβλίο |
Γλώσσα: | English |
Έκδοση: |
Cham :
Springer International Publishing : Imprint: Springer,
2016.
|
Έκδοση: | 1st ed. 2016. |
Θέματα: | |
Διαθέσιμο Online: | Full Text via HEAL-Link |
Πίνακας περιεχομένων:
- Part One: Diagnosis
- History of PSA, from Detection to Over Diagnosis
- Pathology of Prostate Cancer: What has Changed in the Last 30 years?- Clinical Risk Prediction Tools for Prostate Cancer: TMN to CAPRA-Should Risk be Re-defined?- TRUS Biopsy: Is There Still a Role?- Transperineal Biopsy Technique
- 3D Biopsy: A New Method to Diagnose Prostate Cancer
- Elastography: Can it Improve Prostate Biopsy Results?- Multi parametric MRI of the Prostate as a Tool for Prostate Cancer Detection
- Genomic Markers
- Part Two: Treatment
- Current Status of Clinical Trials in Active Surveillance
- Focused targeted Therapy in Prostate Cancer
- Technologies and Methods in Primary Ablation with Focal Therapy
- Multi parametric MRI (mpMRI)-Guided Focal Therapy
- Conclusions.